The rise and fall of raloxifene use for osteoporosis, 1999-2022
Shogry FF, Hayes KN, Kim S, Burden AM, Tadrous M, Aggarwal S, Cadarette SM. Osteoporos Int. 2025 Jun 11 [Epub ahead of prin]t.
- Home
- Research & Analytics
- Research Programs
Chronic Disease & Pharmacotherapy Research Program
The Chronic Disease and Pharmacotherapy (CDP) Research Program has two main areas of emphasis.
Program Overview
Program Lead: Michael Paterson
Program Coordinator: [email protected]
In the Chronic Disease area, researchers track the epidemiology, management and outcomes of chronic illnesses, such as diabetes, arthritis, inflammatory bowel disease, asthma and chronic obstructive pulmonary disease. In the area of Pharmacotherapy, cutting-edge epidemiologic methods are used to examine the real-world use, safety and effectiveness of prescription drugs and drug insurance policies.
ICES Scientists for
Chronic Disease & Pharmacotherapy Research
Explore our directory of ICES Scientists who support province-wide research collaboration.
Partnerships & Collaborations
Canadian Chronic Disease Surveillance System (CCDSS)
Canadian Network for Observational Drug Effect Studies (CNODES)
Ontario Asthma Surveillance Information System (OASIS)
Ontario Drug Policy Research Network (ODPRN)
Discover ICES Research Programs
ICES’ wide-ranging research is organized into eight major programs. These programs support province-wide research collaboration and networking, as well as strategy development and resource planning.